Global Nonalcoholic Steatohepatitis Market

Nonalcoholic Steatohepatitis Market - Global Industry Perspective, Comprehensive Analysis and Forecast, 2014 – 2020

<p>Nonalcoholic steatohepatitis (NASH) is liver inflammation and damage caused by a buildup of fat in the liver. It is also known as silent liver disease. It is a type of nonalcoholic fatty liver disease (NAFLD), which mainly affects people with diabetes and obesity. Nonalcoholic Steatohepatitis (NASH) is defined by histological hallmarks of inflammation, hepatic steatosis, cell death, and fibrosis.&nbsp;&nbsp; A number of drugs used to treat medical situation have been NASH, such as amiodarone (Corderone, Pacerone), tamoxifen (Nolvadex), perhexiline maleate (Pexhid) and steroids (eg, prednisone). Medical studies have identified a strong connection of NASH with certain risk factors such as insulin resistance, oxidative stress and release of toxic inflammatory proteins.</p> <p>Contact US:</p> <h3>Joel John</h3> <p>3422 SW 15 Street,Suit #8138</p> <p>Deerfield Beach,Florida 33442</p> <p>United States</p> <p>Toll Free: +1-855-465-4651 (USA-CANADA)</p> <p>Tel: +1-386-310-3803</p> <p>Email:<a href="">;</a></p> <p>Website <a href=""></a></p>

Florence, AL,
United States


Powered by